When.com Web Search

  1. Ads

    related to: euro lupus guidelines cancer risk reduction medications

Search results

  1. Results From The WOW.Com Content Network
  2. Voclosporin - Wikipedia

    en.wikipedia.org/wiki/Voclosporin

    Voclosporin. Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication for the treatment of lupus nephritis. [2][4] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability. [5]

  3. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [8] and Canada, [9] and the European Union [5] to treat systemic lupus erythematosus and lupus nephritis.

  4. Biogen-UCB's lupus drug meets main goal of late-stage trial - AOL

    www.aol.com/news/biogen-ucbs-lupus-drug-meets...

    September 24, 2024 at 1:04 AM. By Manas Mishra. (Reuters) - Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in patients ...

  5. Lupus - Wikipedia

    en.wikipedia.org/wiki/Lupus

    2–7 per 10,000 [2] Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [1] Common symptoms include painful and swollen joints, fever, chest pain, hair ...

  6. Response evaluation criteria in solid tumors - Wikipedia

    en.wikipedia.org/wiki/Response_Evaluation...

    Response evaluation criteria in solid tumors (RECIST) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment. The criteria were published in February 2000 by an international collaboration including the European Organisation for Research ...

  7. Drug-induced lupus erythematosus - Wikipedia

    en.wikipedia.org/wiki/Drug-induced_lupus_erythe...

    Drug-induced lupus erythematosus is an autoimmune disorder caused by chronic use of certain drugs. These drugs cause an autoimmune response (the body attacks its own cells) producing symptoms similar to those of systemic lupus erythematosus (SLE). There are 38 known medications to cause DIL but there are three that report the highest number of ...

  1. Ad

    related to: euro lupus guidelines cancer risk reduction medications